INDUSTRY NEWS

RWE improving asthma outcomes

28 May 2019
  • 5.4 million people in the UK are currently affected by asthma
  • 3 three year projects will be taking place in Manchester, Edinburgh and Portsmouth respectively
  • Each project set to receive more than £200,000 from innovate and Asthma UK

Click here to see the source article 

Reference

GOV.UK. (2019). Better, faster, more personalised asthma treatment. [online] Available at: https://www.gov.uk/government/news/better-faster-more-personalised-asthma-treatment [Accessed 28 May 2019].

 

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit www.svmpharma.com and contact us at enquiry@svmpharma.com